Indivior discontinues sales and marketing of Perseris (risperidone subcutaneous sustained release) for schizophrenia
Indivior has discontinued sales and marketing for its schizophrenia drug Perseris. This last decision, prompted by increased payor management impacts, is expected to make the product financially unviable… read more.
